Table 1. Patient and nodule characteristics.
Characteristics | Value (%) |
---|---|
Patient characteristics | |
Sex | |
Male | 27 (27.8) |
Female | 70 (72.2) |
Age | 55.0±9.9 |
Nodule size | 9.6±5.0 |
Nodule type | |
Solid | 14 (14.3) |
Part solid GGO | 11 (11.2) |
GGO | 73 (74.5) |
Nodule to pleural distance | 11.1±6.6 |
<10 mm | 41 (41.8) |
10-20 mm | 48 (49.0) |
>20 mm | 9 (9.2) |
Nodule location | |
Right upper lobe (RUL) | 30 (30.6) |
Right middle lobe (RML) | 8 (8.2) |
Right lower lobe (RLL) | 16 (16.3) |
Left upper lobe (LUL) | 27 (27.6) |
Left lower lobe (LLL) | 17 (17.3) |
Final pathology | |
Begin | 12 (12.2) |
AAH | 9 (9.2) |
AIS | 33 (33.7) |
MIA | 15 (15.3) |
Invasive adenocarcinoma | 27 (27.6) |
Metastasis | 2 (2.0) |
Operation data | |
Procedure | |
Sublobar | 57 (58.8) |
Lobectomy after histological confirmation | 30 (30.9) |
Lobectomy | 10 (10.3) |
Margin status | |
Negative | 98 (100.0) |
Positive | 0 |
Intraoperative localization | |
Visual inspection | 66 (67.3) |
Palpation of microcoil | 14 (14.3) |
Palpation of nodule | 15 (15.3) |
Dislocation of microcoil | 3 (3.1) |
Fluoroscopic guidance | 6 (6.1) |
GGO, ground-glass opacity; AAH, atypical adenomatous hyperplasia; AIS, adenocarcinoma in situ; MIA, minimally invasive adenocarcinoma.